CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 34,531 |
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +5,666 | 40,197 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 38,516 |
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +4,000 | 42,516 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 41,329 |
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +3,920 | 45,249 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,163 | $28.96 | $34K | 44,086 |
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 0 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units 10b5-1 | −5,666 | 5,667 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 8,000 | ||
| 2026-03-02 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units 10b5-1 | −3,920 | 7,839 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +4,000 | 68,795 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 67,608 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +5,666 | 73,274 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 71,593 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +4,000 | 75,593 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 74,406 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 0 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −5,666 | 5,667 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 8,000 |
Page 6 of 48 · 941 trades